METTL3 and neoplasm: Lactate in the TME induces METTL3 expression in tumor-infiltrating myeloid cells (TIMs) through histone lysine K18 lactylation, METTL3 lysine K281 and K235 lactylation-mediated RNA m6A modification leads to tumor immune escape by promoting the immunosuppressive function of TIM (108).